Christina Curtis, PhD, MSc is the RZ Cao Professor of Medicine, Genetics, and Biomedical Data Science, Senior Vice Chair of Research in the Department of Medicine and Director of AI and Cancer Genomics at Stanford University. Dr. Curtis’s laboratory leverages computational modeling, high-throughput molecular profiling and experimentation to develop new ways to diagnose, treat and prevent cancer. Her research has redefined the molecular map of breast cancer and led to new paradigms in understanding the origins of human cancers, as well as how they evolve and metastasize.

Dr. Curtis’s accomplishments have been recognized by numerous awards, including the National Institutes of Health (NIH) Director's Pioneer Award in 2018 and the AmericanAssociation for Cancer Research (AACR) Award for Outstanding Achievement in Basic Science in 2022. In 2024 she received the Susan G. Komen Brinker Award for Scientific Distinction in breast cancer research and the AACR/Breast Cancer Research Foundation (BCRF) Award for Outstanding Achievement. In 2025, she received the European Society for Molecular Oncology (ESMO) Translational Award for advancing data-driven approaches for precision oncology. Dr. Curtis is also Susan G. Komen Scholar and ChanZuckerberg Biohub Investigator.

In addition to her research, Dr. Curtis is an influential voice in the scientific, clinical and biopharma communities. She is an advisor to multiple academic institutes, as well as to biopharma, biotech and venture funds. She has served on the editorial boards of Science, Cancer Discovery and Molecular Cancer Research. Dr. Curtis is a past member of the AACR Board of Directors and is Chair of the AACR Data Science Task Force. She is also active within clinical trial cooperative groups, including the Alliance for Clinical Trials in Oncology, and American College of Radiology Imaging Network (ECOG/ACRIN), where she leads correlative science and translational bioinformatics efforts.